Investing

Cara Therapeutic : CARA

CARA

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on itching and pain by selectively targeting kappa opioid receptors in the United States. The company is headquartered in Stamford, Connecticut.

All CARA Articles

3 Articles

Lee Jackson | Mar 9, 2023 at 8:41 AM EST

Thursday’s Top Analyst Downgrades and Upgrades: Costco, CrowdStrike, Dick’s Sporting Goods, GE, PayPal, Six Flags and More

Thursday's top analyst upgrades and downgrades included AGNC Investment, Costco Wholesale, CrowdStrike, Dick’s Sporting Goods, Fifth Third Bancorp, General Electric,…

Chris Lange | Mar 8, 2022 at 2:23 PM EST

Tuesday Afternoon’s Top Analyst Upgrades and Downgrades: Biogen, BP, Caterpillar, Riot Blockchain, Squarespace and More

Tuesday afternoon's top analyst upgrades and downgrades included Biogen, BP, Caterpillar, Riot Blockchain, Squarespace and more.

Chris Lange | Dec 3, 2019 at 10:05 AM EST

Why Mixed Results From This Chronic Kidney Disease Study Aren’t That Great

Cara Therapeutics shares were crushed on Tuesday after the firm announced results from its midstage trial in patients with chronic…